Encompass Health Yönetim
Yönetim kriter kontrolleri 4/4
Encompass Health CEO'su Mark Tarr, Dec2016 tarihinde atandı, in görev süresi 7.92 yıldır. in toplam yıllık tazminatı $ 8.84M olup, şirket hissesi ve opsiyonları dahil olmak üzere 11.9% maaş ve 88.1% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.55% ine doğrudan sahiptir ve bu hisseler $ 56.03M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 11.3 yıl ve 4.8 yıldır.
Anahtar bilgiler
Mark Tarr
İcra Kurulu Başkanı
US$8.8m
Toplam tazminat
| CEO maaş yüzdesi | 11.9% |
| CEO görev süresi | 7.9yrs |
| CEO sahipliği | 0.5% |
| Yönetim ortalama görev süresi | 11.3yrs |
| Yönetim Kurulu ortalama görev süresi | 4.8yrs |
Son yönetim güncellemeleri
Recent updates
Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings
Oct 21
Is Encompass Health (NYSE:EHC) Using Too Much Debt?
Oct 03Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price
May 23Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Encompass Health's (NYSE:EHC) Dividend Will Be $0.15
Mar 09What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?
Feb 25Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Feb 07We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Jan 09Encompass Health (NYSE:EHC) Has Announced A Dividend Of $0.15
Dec 13Encompass Health (NYSE:EHC) Is Due To Pay A Dividend Of $0.15
Nov 28Is There Now An Opportunity In Encompass Health Corporation (NYSE:EHC)?
Nov 21Are Encompass Health Corporation (NYSE:EHC) Investors Paying Above The Intrinsic Value?
Nov 08Is Encompass Health (NYSE:EHC) A Risky Investment?
Oct 10Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Sep 07Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?
Aug 10Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health (NYSE:EHC) Is Paying Out A Dividend Of $0.15
Jul 23Does Encompass Health (NYSE:EHC) Have A Healthy Balance Sheet?
May 22Is Now The Time To Look At Buying Encompass Health Corporation (NYSE:EHC)?
May 01Encompass Health declares $0.15 dividend
Feb 23Encompass Health: Incremental Returns On Capital Key, Confirm Buy
Feb 17Encompass Health 2023 adjusted earnings per share estimate range below consensus
Feb 07Is Now An Opportune Moment To Examine Encompass Health Corporation (NYSE:EHC)?
Jan 23Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M
Oct 26Encompass Health declares $0.15 dividend
Oct 19Should You Investigate Encompass Health Corporation (NYSE:EHC) At US$48.81?
Oct 18Encompass health to build a rehabilitation hospital in the Villages, Florida
Sep 26CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$432m |
| Jun 30 2024 | n/a | n/a | US$409m |
| Mar 31 2024 | n/a | n/a | US$387m |
| Dec 31 2023 | US$9m | US$1m | US$362m |
| Sep 30 2023 | n/a | n/a | US$357m |
| Jun 30 2023 | n/a | n/a | US$336m |
| Mar 31 2023 | n/a | n/a | US$280m |
| Dec 31 2022 | US$8m | US$1m | US$256m |
| Sep 30 2022 | n/a | n/a | US$232m |
| Jun 30 2022 | n/a | n/a | US$242m |
| Mar 31 2022 | n/a | n/a | US$253m |
| Dec 31 2021 | US$8m | US$1m | US$298m |
| Sep 30 2021 | n/a | n/a | US$316m |
| Jun 30 2021 | n/a | n/a | US$318m |
| Mar 31 2021 | n/a | n/a | US$304m |
| Dec 31 2020 | US$7m | US$953k | US$193m |
| Sep 30 2020 | n/a | n/a | US$265m |
| Jun 30 2020 | n/a | n/a | US$285m |
| Mar 31 2020 | n/a | n/a | US$342m |
| Dec 31 2019 | US$7m | US$1m | US$358m |
| Sep 30 2019 | n/a | n/a | US$317m |
| Jun 30 2019 | n/a | n/a | US$308m |
| Mar 31 2019 | n/a | n/a | US$309m |
| Dec 31 2018 | US$6m | US$963k | US$290m |
| Sep 30 2018 | n/a | n/a | US$339m |
| Jun 30 2018 | n/a | n/a | US$316m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$5m | US$900k | US$271m |
Tazminat ve Piyasa: Mark 'nin toplam tazminatı ($USD 8.84M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 12.66M ).
Tazminat ve Kazançlar: Mark 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Mark Tarr (62 yo)
7.9yrs
Görev süresi
US$8,836,376
Tazminat
Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Director | 7.9yrs | US$8.84m | 0.55% $ 56.0m | |
| Executive VP & CFO | 14.5yrs | US$5.75m | 0.26% $ 26.5m | |
| Senior VP & Chief Accounting Officer | 15.1yrs | US$1.10m | 0.076% $ 7.8m | |
| Executive VP | 8.8yrs | US$3.17m | 0.084% $ 8.6m | |
| Chief Medical Officer | 9.3yrs | US$1.30m | 0.018% $ 1.9m | |
| Chief Information Officer & Senior VP | 13.3yrs | Veri yok | Veri yok | |
| Senior Vice President of Investor Relations & Strategic Planning | 3.2yrs | Veri yok | Veri yok | |
| Chief Compliance Officer | 9.3yrs | Veri yok | Veri yok | |
| Chief Human Resources Officer | 4.8yrs | Veri yok | Veri yok | |
| President of Southwest Region | 13.2yrs | Veri yok | Veri yok | |
| President of West Region | 13.2yrs | Veri yok | Veri yok | |
| President of Northeast Region | 16.4yrs | Veri yok | Veri yok |
11.3yrs
Ortalama Görev Süresi
60.5yo
Ortalama Yaş
Deneyimli Yönetim: EHC 'un yönetim ekibi deneyimli ve deneyimlidir ( 11.3 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Director | 7.9yrs | US$8.84m | 0.55% $ 56.0m | |
| Independent Director | 11.8yrs | US$289.80k | 0.00099% $ 100.9k | |
| Independent Director | 11.8yrs | US$294.80k | 0.00099% $ 100.9k | |
| Independent Director | 6.9yrs | US$259.79k | 0.000040% $ 4.1k | |
| Independent Chairman | 4.8yrs | US$276.01k | 0.0038% $ 387.1k | |
| Independent Director | 4.8yrs | US$256.01k | 0.000020% $ 2.0k | |
| Independent Director | 3.1yrs | US$272.98k | 0.012% $ 1.2m | |
| Director | less than a year | US$74.45k | 0.00049% $ 49.9k | |
| Independent Director | 2.7yrs | US$252.54k | 0.0010% $ 101.9k | |
| Independent Director | 4.8yrs | US$271.01k | 0.00035% $ 35.7k |
4.8yrs
Ortalama Görev Süresi
64.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: EHC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.8 yıldır).